Inactive Instrument

Meda AB Stock

Equities

SE0000221723

Pharmaceuticals

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

2016	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
2016	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

Latest news about Meda AB

Meda : Mylan gets EU approval for Meda purchase, subject to conditions	16-07-20	RE
Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	16-07-15	RE
Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	16-06-02	RE
Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	16-03-09	RE
Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	16-02-10	RE
Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	16-01-15	RE
AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	14-07-14	RE
Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	14-07-11	RE
Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	14-07-11	RE
Banks vie for fees as Nordic deal scene ignites	14-05-15	RE
Actavis : Factbox - M&A frenzy transforming global pharma	14-05-06	RE
Actavis : M&A frenzy in healthcare sector	14-05-06	RE
Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	14-05-01	RE
AstraZeneca : Bayer offers animal health assets, cash for Merck's OTC unit -sources	14-04-29	RE
Allergan : Exclusive - Allergan eyes new takeover bid for Shire: sources	14-04-28	RE

Press releases Meda AB

Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	16-08-25	BU
Meda : Delisting of Meda Aktiebolag (publ)	16-08-08	BU
MEDA: Notice to noteholders regarding change of control	16-08-05	BU
Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	16-08-02	BU
Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	16-08-02	BU

More press releases

News in other languages on Meda AB

Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources	16-07-15
Cisco Systems : Wall Street ouvre en net recul	16-02-11
Meda : Mylan annonce le rachat du laboratoire suédois Meda	16-02-11
Mylan versucht es nach Perrigo-Pleite mit Brechstange: Meda-Gebot mit 92% Plus	16-02-10
Allergan préparerait une nouvelle offensive sur Shire	14-04-28

Managers and Directors - Meda AB

Managers	Title	Age	Since
Mårten Österlund FOU	Founder	67	98-12-31
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	62	04-12-31
Hans-Jürgen Tritschler SAM	Sales & Marketing	62	04-12-31

Members of the board	Title	Age	Since
Jacek Glinka CHM	Chairman	60	16-08-24
Colleen Ostrowski BRD	Director/Board Member	51	16-08-24
Caroline Rebecca Louise Dixon BRD	Director/Board Member	56	16-08-24

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+27.97%	672B
NOVO NORDISK A/S	+23.45%	550B
JOHNSON & JOHNSON	-7.02%	351B
MERCK & CO., INC.	+14.85%	317B
ABBVIE INC.	+6.25%	292B
ASTRAZENECA PLC	+2.36%	211B
NOVARTIS AG	-0.72%	203B
ROCHE HOLDING AG	-10.31%	194B
PFIZER, INC.	-11.81%	144B

Other Pharmaceuticals

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer